Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase

Hepatitis C virus (HCV) is an important etiological agent of severe liver diseases, including cirrhosis and hepatocellular carcinoma. The HCV genome encodes nonstructural protein 3 (NS3) helicase, which is a potential anti-HCV drug target because its enzymatic activity is essential for viral replica...

Full description

Bibliographic Details
Main Authors: Atsushi Furuta, Masayoshi Tsubuki, Miduki Endoh, Tatsuki Miyamoto, Junichi Tanaka, Kazi Abdus Salam, Nobuyoshi Akimitsu, Hidenori Tani, Atsuya Yamashita, Kohji Moriishi, Masamichi Nakakoshi, Yuji Sekiguchi, Satoshi Tsuneda, Naohiro Noda
Format: Article
Language:English
Published: MDPI AG 2015-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/16/8/18439
id doaj-335ad083a37c4296872a1cb1855a34d0
record_format Article
spelling doaj-335ad083a37c4296872a1cb1855a34d02020-11-25T01:30:49ZengMDPI AGInternational Journal of Molecular Sciences1422-00672015-08-01168184391845310.3390/ijms160818439ijms160818439Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 HelicaseAtsushi Furuta0Masayoshi Tsubuki1Miduki Endoh2Tatsuki Miyamoto3Junichi Tanaka4Kazi Abdus Salam5Nobuyoshi Akimitsu6Hidenori Tani7Atsuya Yamashita8Kohji Moriishi9Masamichi Nakakoshi10Yuji Sekiguchi11Satoshi Tsuneda12Naohiro Noda13Department of Life Science and Medical Bioscience, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, JapanInstitute of Medical Chemistry, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, JapanInstitute of Medical Chemistry, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, JapanDepartment of Life Science and Medical Bioscience, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, JapanDepartment of Chemistry, Biology and Marine Science, University of the Ryukyus, Nishihara, Okinawa 903-0213, JapanRadioisotope Center, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo 113-0032, JapanRadioisotope Center, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo 113-0032, JapanEnvironmental Measurement Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, JapanDepartment of Microbiology, Division of Medicine, Graduate School of Medicine and Engineering, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, JapanDepartment of Microbiology, Division of Medicine, Graduate School of Medicine and Engineering, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, JapanDepartment of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi-shi, Chiba 274-8510, JapanBiomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, JapanDepartment of Life Science and Medical Bioscience, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, JapanDepartment of Life Science and Medical Bioscience, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, JapanHepatitis C virus (HCV) is an important etiological agent of severe liver diseases, including cirrhosis and hepatocellular carcinoma. The HCV genome encodes nonstructural protein 3 (NS3) helicase, which is a potential anti-HCV drug target because its enzymatic activity is essential for viral replication. Some anthracyclines are known to be NS3 helicase inhibitors and have a hydroxyanthraquinone moiety in their structures; mitoxantrone, a hydroxyanthraquinone analogue, is also known to inhibit NS3 helicase. Therefore, we hypothesized that the hydroxyanthraquinone moiety alone could also inhibit NS3 helicase. Here, we performed a structure–activity relationship study on a series of hydroxyanthraquinones by using a fluorescence-based helicase assay. Hydroxyanthraquinones inhibited NS3 helicase with IC50 values in the micromolar range. The inhibitory activity varied depending on the number and position of the phenolic hydroxyl groups, and among different hydroxyanthraquinones examined, 1,4,5,8-tetrahydroxyanthraquinone strongly inhibited NS3 helicase with an IC50 value of 6 µM. Furthermore, hypericin and sennidin A, which both have two hydroxyanthraquinone-like moieties, were found to exert even stronger inhibition with IC50 values of 3 and 0.8 µM, respectively. These results indicate that the hydroxyanthraquinone moiety can inhibit NS3 helicase and suggest that several key chemical structures are important for the inhibition.http://www.mdpi.com/1422-0067/16/8/18439hepatitis C virusNS3 helicasefluorescence resonance energy transferinhibitorhydroxyanthraquinonehypericinsennidin A
collection DOAJ
language English
format Article
sources DOAJ
author Atsushi Furuta
Masayoshi Tsubuki
Miduki Endoh
Tatsuki Miyamoto
Junichi Tanaka
Kazi Abdus Salam
Nobuyoshi Akimitsu
Hidenori Tani
Atsuya Yamashita
Kohji Moriishi
Masamichi Nakakoshi
Yuji Sekiguchi
Satoshi Tsuneda
Naohiro Noda
spellingShingle Atsushi Furuta
Masayoshi Tsubuki
Miduki Endoh
Tatsuki Miyamoto
Junichi Tanaka
Kazi Abdus Salam
Nobuyoshi Akimitsu
Hidenori Tani
Atsuya Yamashita
Kohji Moriishi
Masamichi Nakakoshi
Yuji Sekiguchi
Satoshi Tsuneda
Naohiro Noda
Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase
International Journal of Molecular Sciences
hepatitis C virus
NS3 helicase
fluorescence resonance energy transfer
inhibitor
hydroxyanthraquinone
hypericin
sennidin A
author_facet Atsushi Furuta
Masayoshi Tsubuki
Miduki Endoh
Tatsuki Miyamoto
Junichi Tanaka
Kazi Abdus Salam
Nobuyoshi Akimitsu
Hidenori Tani
Atsuya Yamashita
Kohji Moriishi
Masamichi Nakakoshi
Yuji Sekiguchi
Satoshi Tsuneda
Naohiro Noda
author_sort Atsushi Furuta
title Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase
title_short Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase
title_full Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase
title_fullStr Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase
title_full_unstemmed Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase
title_sort identification of hydroxyanthraquinones as novel inhibitors of hepatitis c virus ns3 helicase
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2015-08-01
description Hepatitis C virus (HCV) is an important etiological agent of severe liver diseases, including cirrhosis and hepatocellular carcinoma. The HCV genome encodes nonstructural protein 3 (NS3) helicase, which is a potential anti-HCV drug target because its enzymatic activity is essential for viral replication. Some anthracyclines are known to be NS3 helicase inhibitors and have a hydroxyanthraquinone moiety in their structures; mitoxantrone, a hydroxyanthraquinone analogue, is also known to inhibit NS3 helicase. Therefore, we hypothesized that the hydroxyanthraquinone moiety alone could also inhibit NS3 helicase. Here, we performed a structure–activity relationship study on a series of hydroxyanthraquinones by using a fluorescence-based helicase assay. Hydroxyanthraquinones inhibited NS3 helicase with IC50 values in the micromolar range. The inhibitory activity varied depending on the number and position of the phenolic hydroxyl groups, and among different hydroxyanthraquinones examined, 1,4,5,8-tetrahydroxyanthraquinone strongly inhibited NS3 helicase with an IC50 value of 6 µM. Furthermore, hypericin and sennidin A, which both have two hydroxyanthraquinone-like moieties, were found to exert even stronger inhibition with IC50 values of 3 and 0.8 µM, respectively. These results indicate that the hydroxyanthraquinone moiety can inhibit NS3 helicase and suggest that several key chemical structures are important for the inhibition.
topic hepatitis C virus
NS3 helicase
fluorescence resonance energy transfer
inhibitor
hydroxyanthraquinone
hypericin
sennidin A
url http://www.mdpi.com/1422-0067/16/8/18439
work_keys_str_mv AT atsushifuruta identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase
AT masayoshitsubuki identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase
AT midukiendoh identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase
AT tatsukimiyamoto identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase
AT junichitanaka identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase
AT kaziabdussalam identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase
AT nobuyoshiakimitsu identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase
AT hidenoritani identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase
AT atsuyayamashita identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase
AT kohjimoriishi identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase
AT masamichinakakoshi identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase
AT yujisekiguchi identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase
AT satoshitsuneda identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase
AT naohironoda identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase
_version_ 1725089609558261760